Development and validation of a spectrofluorimetric method for the estimation of rivastigmine in formulations
about
In vivo 3D measurement of moxifloxacin and gatifloxacin distributions in the mouse cornea using multiphoton microscopyQbD-oriented development and validation of a bioanalytical method for nevirapine with enhanced liquid-liquid extraction and chromatographic separation.Systematic Development and Validation of a Thin-Layer Densitometric Bioanalytical Method for Estimation of Mangiferin Employing Analytical Quality by Design (AQbD) Approach.Buccoadhesive films for once-a-day administration of rivastigmine: systematic formulation development and pharmacokinetic evaluation.QbD-Driven Development and Validation of a HPLC Method for Estimation of Tamoxifen Citrate with Improved Performance.Development and Validation of a Stability-Indicating Liquid Chromatographic Method for Estimating Olmesartan Medoxomil Using Quality by Design.
P2860
Development and validation of a spectrofluorimetric method for the estimation of rivastigmine in formulations
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Development and validation of ...... f rivastigmine in formulations
@en
type
label
Development and validation of ...... f rivastigmine in formulations
@en
prefLabel
Development and validation of ...... f rivastigmine in formulations
@en
P2093
P2860
P356
P1476
Development and validation of ...... f rivastigmine in formulations
@en
P2093
Bhupinder Singh
P2860
P304
P356
10.4103/0250-474X.58179
P577
2009-09-01T00:00:00Z